Renghalin, tablets 20 pcs

It was shown experimentally that the drug components modify the activity of ligand-receptor interaction of endogenous regulators with the corresponding receptors: antibodies to morphine – with opiate receptors; antibodies to histamine – with H1-histamine receptors; antibodies to bradykinin – with B1-bradykinin receptors; the combined use of components leads to a stronger anti-cough effect.

In addition to the anti-coughing effect, the complex drug due to its components has anti-inflammatory, anti-edema, anti-allergic, antispasmodic (antibodies to histamine, antibodies to bradykinin) and analgesic effect (antibodies to morphine).

Complex preparation Rengalin due to modification of histamine-dependent activation of H1-receptors and bradykinin-dependent activation of B2-receptors selectively decreases excitability of the medulla oblongata cough center and inhibits central links of the cough reflex. Inhibiting centers of pain sensitivity in the thalamus, blocks the transmission of pain impulses to the cerebral cortex. Inhibits the flow of pain impulses from the periphery by reducing the release of tissue and plasma algogens (histamine, bradykinin, prostaglandins, etc.). Unlike narcotic analgesics it does not cause respiratory depression, drug addiction, has no narcogenic and hypnotic effect.

Relieves symptoms of acute pharyngitis, laryngitis and bronchitis, reducing bronchospasm. Cures systemic and local symptoms of allergic reactions through its effect on the synthesis and release of histamine and bradykinin from mast cells.

Indications

Tracheitis, Laryngitis, Colds, Pharyngitis, Bronchitis, Influenza, CoughRengalin is indicated for use in adults and children from 3 years.

Productive and non-productive cough in influenza and SARS, acute pharyngitis, laryngotracheitis, acute obstructive laryngitis, chronic bronchitis and other inflammatory and allergic diseases of the upper and lower respiratory tract.

Active ingredient

Antibodies

Composition

Composition (per tablet):

Active ingredients:

Antibodies to bradykinin affinity purified – 0.006 g*

Antibodies to histamine affinity purified – 0.006 g*

How to take, the dosage

Risk is not intended to divide the tablet into parts.

Inside.

At one reception – 1 tablet (keep in the mouth until complete dissolution). Use 1-2 tablets 3 times a day without taking food. Depending on the severity of the condition during the first three days the frequency of intake may be increased to 4-6 times a day.

Duration of therapy depends on the severity of the disease and is determined by the attending physician.

Interaction

During the conducted clinical trials, there were no data on the interaction of the drug Rengalin with drugs used as concomitant therapy.

Synopsis

Tablets are flat-cylindrical, beveled, with a ridge on one flat side, with solid edges, white to almost white.

On the flat side with a ridge printed MATERIA MEDICA, on the other flat side is the inscription RENGALIN.

Contraindications

Children under 3 years of age.

Increased individual sensitivity to the drug components.

Hereditary intolerance to fructose (due to the presence of maltitol).

Side effects

Individual hypersensitivity reactions to the drug components are possible.

Overdose

In case of accidental overdose, dyspeptic phenomena (nausea, vomiting, diarrhea) are possible due to the fillers included in the drug (maltitol, glycerol).

Treatment – symptomatic.

Pregnancy use

The safety of using Rengalin in pregnant women and during breastfeeding has not been studied. If it is necessary to take the drug, the benefit-risk ratio should be taken into account.

Similarities

Proproten-100, Anaferon, Tenoten, Afala, Colophort, Impaza, Artrofon, Divase, Afalaza, Tenoten for children, Anaferon for children